Encounter for surveillance of contraceptive pills 2016 2017 2018 2019 2020 2021 Billable/Specific Code POA Exempt Z30.41 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z30.41 became effective on October 1, 2020.
Z30.41 is a billable ICD code used to specify a diagnosis of encounter for surveillance of contraceptive pills. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Z79.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.3 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.3 - other international versions of ICD-10 Z79.3 may differ. Z codes represent reasons for encounters.
Z30.41 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30.41 became effective on October 1, 2021. This is the American ICD-10-CM version of Z30.41 - other international versions of ICD-10 Z30.41 may differ. Z codes represent reasons for encounters.
Encounter for surveillance of other contraceptives Z30. 49 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30. 49 became effective on October 1, 2021.
Z30.9Z30. 9 - Encounter for contraceptive management, unspecified | ICD-10-CM.
ICD-10 Code for Encounter for surveillance of injectable contraceptive- Z30.
ICD-10 Code for Encounter for initial prescription of contraceptive pills- Z30. 011- Codify by AAPC.
Codes 99401-99404 are reported when the entire encounter is for preventive medicine counseling (contraceptive and/or STI). The diagnosis code is Z30. 09 (encounter for other general contraception counseling).
Contraceptive counseling is a common and important patient–clinician interaction. When approached through a framework of reproductive justice, contraceptive counseling helps patients achieve their reproductive goals in a manner consistent with their priorities, values, and lived experiences.
J1050 Injection, medroxyprogesterone acetate, 1 mg is used to bill for the Depo- Provera drug administered.
ICD-10 code T80 for Complications following infusion, transfusion and therapeutic injection is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .
Effective January 1, 2013, injection administration of medroxyprogesterone acetate (Depo-Provera) should be reported using HCPCS code J1050 (Injection, medroxyprogesterone acetate, 1 mg).
ICD-10 code Z30. 09 for Encounter for other general counseling and advice on contraception is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
411, Encounter for gynecological examination (general) (routine) with abnormal findings, or Z01. 419, Encounter for gynecological examination (general) (routine) without abnormal findings, may be used as the ICD-10-CM diagnosis code for the annual exam performed by an obstetrician–gynecologist.
ICD-10 code N92. 6 for Irregular menstruation, unspecified is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
Code is only used for female patients. Code is only used for diagnoses related to pregnancy. Z30.41 is a billable ICD code used to specify a diagnosis of encounter for surveillance of contraceptive pills. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. The Center for Medicare & Medicaid Services (CMS) requires medical coders to indicate whether or not a condition was present at the time of admission, in order to properly assign MS-DRG codes.